Skip to main content

Ventas Inc

For the period ended May 14, 2024. Filed Apr 2, 2024.

View on SEC.gov

About this filing

What shareholders are asked to vote on at a company's meeting. It is where to find what directors and top executives are paid, and who owns the most shares.

May 14, 2024 · Filed Apr 2, 2024

VTR$88.75-0.3%Stored close · as of Nov 6, 2026
See the whole filing, with its images and exhibits

Pay vs. Performance

2023 Pay vs. Performance

Pay vs. Performance Table

As required by Section 953(a) of the Dodd-Frank Wall Street Reform and Consumer Protection Act and Item 402(v) of Regulation S-K, we are providing the following information about “Compensation Actually Paid,” as defined by the SEC and in Footnote 2 below, and certain financial performance of the Company.

862024 | Proxy Statement
Average Summary Compensation Table Total for Other NEOs(1) · Average Compensation Actually Paid to Other NEOs(2) · Value of Initial Fixed $100 Investment Based On:
Year · Summary Compensation Table Total for CEO(1) · Compensation Actually Paid to CEO(2) · TotalShareholderReturn(TSR) · FTSE NareitEquityHealth CareIndex TSR(3) · GAAPNetIncome (Loss)(in 000s) · NormalizedFFO/Share(4)
2023$13,520,625$10,139,836$4,107,540$3,806,036$102.39$92.96$(40,973)$2.99
202214,059,09217,813,6414,224,7534,826,76688.9781.59(47,447)2.99
202114,263,7289,914,4526,012,8105,967,43797.29104.8549,0082.90
202012,628,7149,443,1125,404,6814,924,46390.2990.14439,1493.32

(1)The Named Executive Officers in the fiscal years identified above were:

YearCEOOther NEOs
2023Debra A. CafaroPeter J. Bulgarelli, J. Justin Hutchens, Carey S. Roberts and Robert F. Probst
2022Debra A. CafaroPeter J. Bulgarelli, John D. Cobb, J. Justin Hutchens and Robert F. Probst
2021Debra A. CafaroPeter J. Bulgarelli, John D. Cobb, J. Justin Hutchens and Robert F. Probst
2020Debra A. CafaroJohn D. Cobb, J. Justin Hutchens, Robert F. Probst and Carey S. Roberts

(2)“Compensation Actually Paid”is defined by the SEC as the total compensation reported in the Summary Compensation Table for the applicable fiscal year adjusted as follows:

2020202120222023
AdjustmentsCEOAverage Other NEOsCEOAverage Other NEOsCEOAverage Other NEOsCEOAverage Other NEOs
Deduction for Amounts Reported under the “Stock Awards” and “Option Awards” Columns in the Summary Compensation Table for Applicable FY(9,509,954)(3,720,262)(11,013,974)(4,380,687)(9,666,901)(2,437,396)(9,598,375)(2,393,832)
Increase based on ASC 718 Fair Value of Awards Granted during Applicable FY that Remain Unvested as of Applicable FY End, determined as of Applicable FY End9,307,2633,602,55610,897,3234,375,2049,370,1052,300,7017,859,9252,004,184
Increase based on ASC 718 Fair Value of Awards Granted during Applicable FY that Vested during Applicable FY, determined as of Vesting Date————————
Increase/deduction for Awards Granted during Prior FY that were Outstanding and Unvested as of Applicable FY End, determined based on change in ASC 718 Fair Value from Prior FY End to Applicable FY End(1,207,093)(199,761)(2,221,470)(19,974)478,362(108,888)(3,129,391)(380,161)
2024 | Proxy Statement87
2020 · 2021 · 2022 · 2023
Adjustments · CEO · Average Other NEOs · CEO · Average Other NEOs · CEO · Average Other NEOs · CEO · Average Other NEOs
Increase/deduction for Awards Granted during Prior FY that Vested During Applicable FY, determined based on change in ASC 718 Fair Value from Prior FY End to Vesting Date(1,182,102)(154,234)121,077182,8363,244,357671,289327,101177,586
Deduction of ASC 718 Fair Value of Awards Granted during Prior FY that were Forfeited during Applicable FY, determined as of Prior FY End(1,094,539)(166,103)(2,323,203)(334,555)(503,173)(94,075)——
Increase based on Dividends or Other Earnings Paid during Applicable FY prior to Vesting Date500,822157,586190,971131,803831,798270,3821,159,951290,720
Increase based on Incremental Fair Value of Options/SARs Modified during Applicable FY————————
Deduction for Change in the Actuarial Present Values reported under the “Change in Pension Value and Nonqualified Deferred Compensation Earnings” Column of the Summary Compensation Table for Applicable————————
Increase for Service Cost and, if applicable, Prior Service Cost for Pension Plans———————
TOTAL ADJUSTMENTS(3,185,602)(480,218)(4,349,276)(45,373)3,754,549602,013(3,380,789)(301,504)

(3)Total Shareholder Return and FTSE Nareit Equity Health Care Index Total Shareholder Return reflect the return a stockholder would have recognized at the end of each of the fiscal years shown had they invested $100 in the Company or the FTSE Nareit Equity Health Care Index, respectively, on January 1, 2000. We have chosen to include the FTSE Nareit Equity Health Care Index TSR as our peer group TSR in this table as this is one of the primary measures of performance used in our long-term incentive plan.

(4)Normalized FFO/Share is one of the primary measures used in our Annual Incentive Plan. Historical cost accounting for real estate assets implicitly assumes that the value of real estate assets diminishes predictably over time. However, because real estate values historically have risen or fallen with market conditions, many industry investors deem presentations of operating results for real estate companies that use historical cost accounting to be insufficient by themselves. For that reason, we consider Funds From Operations attributable to common stockholders (“FFO”) and Normalized FFO to be appropriate supplemental measures of operating performance of an equity REIT. For information regarding the calculation of Normalized FFO, please see Appendix A. To calculate Normalized FFO on per share basis, Normalized FFO is divided by weighted average diluted shares as set forth in Note 15 of our 2023 Form 10-K.

882024 | Proxy Statement

Relationship Between Compensation Actually Paid and Financial Performance Measures

The line graphs below compare Compensation Actually Paid to our CEO and the average Compensation Actually Paid to our Other NEOs to (i) our cumulative TSR, (ii) FTSE Nareit Equity Health Care Index TSR (“Nareit TSR”), (iii) our Net Income (Loss) and (iv) our Normalized FFO/Share, in each case, for the fiscal years ended December 31, 2020, 2021, 2022 and 2023.

TSR amounts assume an initial fixed investment of $100, and that any dividends were reinvested.

Compensation Actually Paid Versus Cumulative TSR

CEO Compensation Actually Paid ($)Other NEO Average Compensation Actually Paid ($)
Ventas Total Shareholder Return ($)FTSE NAREIT Equity Health Care Index TSR ($)
2024 | Proxy Statement89

Compensation Actually Paid Versus Net Income (Loss) (in $000s)

CEO Compensation Actually Paid ($)Other NEO Average Compensation Actually Paid ($)
Net Income (in $000s)

Compensation Actually Paid Versus Normalized Funds from Operations per Share ($)

CEO Compensation Actually Paid ($)Other NEO Average Compensation Actually Paid ($)
Normalized Funds from Operations per Share ($)
902024 | Proxy Statement

Key Financial Performance Measures

The following performance measures represent the most important financial performance measures used by us to link compensation actually paid to our Named Executive Officers for the fiscal year ended December 31, 2023 to company performance:

Financial Performance Measures Linked to the Compensation of Named Executive Officers

Normalized FFO per Share

Fixed Charge Coverage

TSR Relative to the FTSE Nareit Equity Health Care Index

TSR Relative to the MSCI U.S. REIT Index

Net Debt to Further Adjusted EBITDA

See the discussions of our annual and long-term incentive programs in “Compensation Discussion & Analysis” for further information regarding the use of these metrics in our executive compensation program.

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.